pargyline has been researched along with thiourea in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Breese, GR; Cooper, BR; Hollister, AS | 1 |
| Korduba, CA; Symchowicz, S; Veals, J | 1 |
| Reichenberg, K; Vetulani, J | 1 |
| Boukma, SJ; Johnson, GA; Kim, EG | 1 |
| Barnes, W; Boyd, D; Hough, L | 1 |
| De, CK; Klauber, EG; Seidel, D; Shah, TK | 1 |
| Dong, SN; Gong, Q; Li, J; Li, XK; Liu, WW; Mao, F; Tang, Y; Wang, H; Wang, TD; Xu, YX; Zhang, HY; Zhu, J | 1 |
| Bhatia, M; Kapoor, A; Kumar, A; Kumar, P; Kumar, S | 1 |
1 review(s) available for pargyline and thiourea
| Article | Year |
|---|---|
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
Topics: Aldehydes; Ammonia; Caffeine; Chalcones; Chromones; Clorgyline; Coumarins; Hydrogen Peroxide; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Pyrazoles; Selegiline; Structure-Activity Relationship; Thiazoles; Thiourea | 2022 |
7 other study(ies) available for pargyline and thiourea
| Article | Year |
|---|---|
Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
Topics: Animals; Brain; Brain Chemistry; Desipramine; Dextroamphetamine; Dopamine; Dopamine beta-Hydroxylase; Humans; Hydrazines; Hydroxydopamines; Iproniazid; Male; Methyltyrosines; Motor Activity; Norepinephrine; Pargyline; Reserpine; Stereotyped Behavior; Thiourea; Time Factors; Tyrosine 3-Monooxygenase | 1974 |
Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
Topics: Amides; Animals; Brain; Brain Chemistry; Carbon Radioisotopes; Catecholamines; Cerebral Ventricles; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Ethanol; Hydroxyindoleacetic Acid; Indoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Pargyline; Picolinic Acids; Rats; Serotonin; Stimulation, Chemical; Thiazoles; Thiourea | 1974 |
Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
Topics: Amines; Animals; Brain; Cerebral Ventricles; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Injections; Male; Monoamine Oxidase Inhibitors; Nialamide; Norepinephrine; Pargyline; Picolinic Acids; Rats; Reserpine; Serotonin; Thiocarbamates; Thiourea | 1973 |
5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
Topics: Administration, Oral; Animals; Brain; Brain Chemistry; Circadian Rhythm; Disulfiram; Dopamine beta-Hydroxylase; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Male; Methyltyrosines; Mixed Function Oxygenases; Monoiodotyrosine; Norepinephrine; Pargyline; Rats; Rats, Inbred Strains; Serotonin; Thiazoles; Thiourea; Time Factors | 1972 |
Dynamics of histamine H(3) receptor antagonists on brain histamine metabolism: do all histamine H(3) receptor antagonists act at a single site?
Topics: Analysis of Variance; Animals; Binding Sites; Brain; Histamine; Histamine Antagonists; Imidazoles; Male; Methylhistamines; Mice; Pargyline; Piperidines; Rats; Receptors, Histamine H3; Thiourea | 2001 |
Merging nucleophilic and hydrogen bonding catalysis: an anion binding approach to the kinetic resolution of propargylic amines.
Topics: 4-Aminopyridine; Amides; Anions; Binding Sites; Catalysis; Hydrogen Bonding; Kinetics; Molecular Structure; Pargyline; Propylamines; Stereoisomerism; Thiourea | 2010 |
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Pyrimidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea | 2018 |